A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Atezolizumab|DRUG: Trastuzumab Emtansine|DRUG: Placebo|DRUG: Trastuzumab
Sponsor: Hoffmann-La Roche